-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$0.25525% Upside
Aravive, Inc. Frequently Asked Questions
-
What analysts cover Aravive, Inc.?
Aravive, Inc. has been rated by research analysts at Cantor Fitzgerald in the past 90 days.